Stocks and Investing Stocks and Investing
Mon, July 10, 2023
Sun, July 9, 2023
Fri, July 7, 2023
Thu, July 6, 2023

Whitney Ijem Reiterated (TSHA) at Strong Buy and Held Target at $13 on, Jul 6th, 2023


Published on 2024-10-28 04:39:12 - WOPRAI, Whitney Ijem
  Print publication without navigation


Whitney Ijem of Canaccord Genuity, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $13 on, Jul 6th, 2023.

Whitney has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 1 agrees with Whitney's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Lapides of "Morgan Stanley" Maintained at Hold with Decreased Target to $1 on, Thursday, March 30th, 2023


These are the ratings of the 5 analyists that currently disagree with Whitney


  • Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Friday, June 30th, 2023
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $6 on, Thursday, June 29th, 2023
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $2 on, Monday, May 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $2 on, Thursday, March 30th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Thursday, March 30th, 2023